Neonatal admission after lithium use in pregnant women with bipolar disorders: a retrospective cohort study

BACKGROUND: Lithium is the preferred treatment for pregnant women with bipolar disorders (BD), as it is most effective in preventing postpartum relapse. Although it has been prescribed during pregnancy for decades, the safety for neonates and obstetric outcomes are a topic of ongoing scientific deba...

Descripción completa

Detalles Bibliográficos
Autores principales: Schonewille, Noralie N., Terpstra, Pleun A., van den Heuvel, Maria E. N., Van Pampus, Maria G., van den Heuvel, Odile A., Broekman, Birit F. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348961/
https://www.ncbi.nlm.nih.gov/pubmed/37450192
http://dx.doi.org/10.1186/s40345-023-00306-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348961/
https://www.ncbi.nlm.nih.gov/pubmed/37450192
http://dx.doi.org/10.1186/s40345-023-00306-7

Ejemplares similares